Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

181 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Talazoparib in Patients With Solid Tumors With BRCA1/2 Mutation: Results From the Targeted Agent and Profiling Utilization Registry Study.
Srkalovic G, Rothe M, Mangat PK, Garrett-Mayer E, Ahn ER, Brouse G, Chan J, Mehmi I, Khalil M, Duvivier HL, Gaba A, Leuva H, Thota R, Yost KJ, Grantham GN, Gregory A, Hinshaw DC, Halabi S, Schilsky RL. Srkalovic G, et al. Among authors: gaba a. JCO Precis Oncol. 2024 Jun;8:e2400026. doi: 10.1200/PO.24.00026. JCO Precis Oncol. 2024. PMID: 38865672 Clinical Trial.
Pertuzumab Plus Trastuzumab in Patients With Lung Cancer With ERBB2 Mutation or Amplification: Results From the Targeted Agent and Profiling Utilization Registry Study.
Ganti AK, Rothe M, Mangat PK, Garrett-Mayer E, Dib EG, Duvivier HL, Ahn ER, Behl D, Borghaei H, Balmanoukian AS, Gaba A, Li R, Osei-Boateng K, Thota R, Grantham GN, Gregory A, Halabi S, Schilsky RL. Ganti AK, et al. Among authors: gaba a. JCO Precis Oncol. 2023 Jun;7:e2300041. doi: 10.1200/PO.23.00041. JCO Precis Oncol. 2023. PMID: 37315265 Clinical Trial.
Sunitinib in Patients With Breast Cancer With FGFR1 or FGFR2 Amplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.
Calfa CJ, Rothe M, Mangat PK, Garrett-Mayer E, Ahn ER, Burness ML, Gogineni K, Rohatgi N, Al Baghdadi T, Conlin A, Gaba A, Hamid O, Krishnamurthy J, Gavini NJ, Gold PJ, Rodon J, Rueter J, Thota R, Grantham GN, Hinshaw DC, Gregory A, Halabi S, Schilsky RL. Calfa CJ, et al. Among authors: gaba a. JCO Precis Oncol. 2024 Feb;8:e2300513. doi: 10.1200/PO.23.00513. JCO Precis Oncol. 2024. PMID: 38354330
Health equity engineering: Optimizing hope for a new generation of healthcare.
Enders FT, Golembiewski EH, Balls-Berry JE, Brooks TR, Carr AR, Cullen JP, DiazGranados D, Gaba A, Johnson L, Menser T, Messinger S, Milam AJ, Orellana MA, Perkins SM, Pineda TDC, Thurston SW, Periyakoil VS, Hanlon AL. Enders FT, et al. Among authors: gaba a. J Clin Transl Sci. 2024 May 23;8(1):e136. doi: 10.1017/cts.2024.549. eCollection 2024. J Clin Transl Sci. 2024. PMID: 39478773 Free PMC article.
Improving National and International Surveillance of Movement Behaviours in Childhood and Adolescence: An International Modified Delphi Study.
Reilly JJ, Andrew R, Abdeta C, Azevedo LB, Farias NA, Barak S, Bardid F, Bizzozero-Peroni B, Brazo-Sayavera J, Cagas JY, Chelly MS, Christiansen LB, Djordjic VD, Draper CE, El-Hamdouchi A, Fares EJ, Gába A, Hesketh KD, Hossain MS, Huang W, Jáuregui A, Juvekar SK, Kuzik N, Larouche R, Lee EY, Levi S, Liu Y, Löf M, Loney T, Gil JFL, Mäestu E, Manyanga T, Martins C, Mendoza-Muñoz M, Morrison SA, Munambah N, Mwase-Vuma TW, Naidoo R, Ocansey R, Okely AD, Oluwayomi A, Paudel S, Poh BK, Ribeiro EH, Silva DAS, Shahril MR, Smith M, Staiano AE, Standage M, Subedi N, Tanaka C, Tang HK, Thivel D, Tremblay MS, Uzicanin E, Vlachopoulos D, Webster EK, Widyastari DA, Zembura P, Aubert S. Reilly JJ, et al. Among authors: gaba a. Sports Med. 2024 Oct 3. doi: 10.1007/s40279-024-02104-2. Online ahead of print. Sports Med. 2024. PMID: 39361231
181 results